Authors:
TANABE T
KOMINSKY SL
SUBRAMANIAM PS
JOHNSON HM
TORRES BA
Citation: T. Tanabe et al., CELL-CYCLE INHIBITION BY TYPE-I IFNS OCCURS AT BOTH THE G1 AND S-PHASE AND CORRELATES WITH UP-REGULATION OF P21(WAF1), The FASEB journal, 12(4), 1998, pp. 1646-1646
Authors:
TORRES BA
TANABE T
SUBRAMANIAM PS
YAMAMOTO JK
JOHNSON HM
Citation: Ba. Torres et al., MECHANISM OF HIV PATHOGENESIS - ROLE OF SUPERANTIGENS IN DISEASE, Alcoholism, clinical and experimental research, 22(5), 1998, pp. 188-192
Authors:
JOHNSON HM
TORRES BA
GREEN MM
SZENTE BE
SILER KI
LARKIN J
SUBRAMANIAM PS
Citation: Hm. Johnson et al., HYPOTHESIS - LIGAND RECEPTOR-ASSISTED NUCLEAR TRANSLOCATION OF STATS/, Proceedings of the Society for Experimental Biology and Medicine, 218(3), 1998, pp. 149-155
Authors:
JOHNSON HM
TORRES BA
GREEN MM
SZENTE BE
SILER KI
LARKIN J
SUBRAMANIAM PS
Citation: Hm. Johnson et al., CYTOKINE-RECEPTOR COMPLEXES AS CHAPERONES FOR NUCLEAR TRANSLOCATION OF SIGNAL TRANSDUCERS, Biochemical and biophysical research communications, 244(3), 1998, pp. 607-614
Authors:
SOOS JM
SCHIFFENBAUER J
TORRES BA
JOHNSON HM
Citation: Jm. Soos et al., SUPERANTIGENS AS VIRULENCE FACTORS IN AUTOIMMUNITY AND IMMUNODEFICIENCY DISEASES, Medical hypotheses, 48(3), 1997, pp. 253-259
Authors:
TANABE T
TORRES BA
SUBRAMANIAM PS
JOHNSON HM
Citation: T. Tanabe et al., V-BETA ACTIVATION BY HIV NEF PROTEIN - DETECTION BY A SIMPLE AMPLIFICATION PROCEDURE, Biochemical and biophysical research communications, 230(3), 1997, pp. 509-513
Authors:
SZENTE BE
WEINER IJ
JABLONSKY MJ
KRISHNA NR
TORRES BA
JOHNSON HM
Citation: Be. Szente et al., STRUCTURAL REQUIREMENTS FOR AGONIST ACTIVITY OF A MURINE INTERFERON-GAMMA PEPTIDE, Journal of interferon & cytokine research, 16(10), 1996, pp. 813-817
Authors:
TANABE T
TORRES BA
SUBRAMANIAM P
JOHNSON HM
Citation: T. Tanabe et al., HIV NEF - A SIMPLE METHOD FOR MAPPING THE V-BETA PROFILE OF A WEAK SUPERANTIGEN, The FASEB journal, 10(6), 1996, pp. 1839-1839
Citation: Ba. Torres et al., REPLICATION OF HIV-1 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS ACTIVATED BY EXOGENOUS NEF, AIDS, 10(9), 1996, pp. 1042-1043
Citation: Hm. Johnson et al., SUPERANTIGENS - STRUCTURE AND RELEVANCE TO HUMAN-DISEASE, Proceedings of the Society for Experimental Biology and Medicine, 212(2), 1996, pp. 99-109
Authors:
HUDAK ML
FARRELL EE
ROSENBERG AA
JUNG AL
AUTEN RL
DURAND DJ
HORGAN MJ
BUCKWALD S
BELCASTRO MR
DONOHUE PK
CARRION V
MANISCALCO WW
BALSAN MJ
TORRES BA
MILLER RR
JANSEN RD
GRAEBER JE
LASKAY KM
MATTESON EJ
EGAN EA
BRODY AS
MARTIN DJ
RIDDLESBERGER MM
MONTGOMERY P
Citation: Ml. Hudak et al., A MULTICENTER RANDOMIZED, MASKED COMPARISON TRIAL OF NATURAL VERSUS SYNTHETIC SURFACTANT FOR THE TREATMENT OF RESPIRATORY-DISTRESS SYNDROME, The Journal of pediatrics, 128(3), 1996, pp. 396-406
Authors:
TORRES BA
TANABE T
YAMAMOTO JK
JOHNSON HM
Citation: Ba. Torres et al., HIV ENCODES FOR ITS OWN CD4 T-CELL SUPERANTIGEN MITOGEN, Biochemical and biophysical research communications, 225(2), 1996, pp. 672-678
Citation: Ba. Torres et al., CHARACTERIZATION OF NEF-INDUCED CD4 T-CELL PROLIFERATION, Biochemical and biophysical research communications, 225(1), 1996, pp. 54-61
Citation: Ji. Rayon et al., INCREASED SEVERITY OF ILLNESS IN MATERNALLY TRANSPORTED NEONATES AS ACONTRIBUTING FACTOR TO THE IN-BORN NEONATAL-MORTALITY RATE OBSERVED IN A TERTIARY CARE NICU DURING DEREGIONALIZATION, Pediatric research, 37(4), 1995, pp. 270-270
Authors:
STROMQUIST CI
EMMANUEL P
OJEDA F
VALENCIA P
RAYON J
TORRES BA
CURRAN JS
NELSON RM
Citation: Ci. Stromquist et al., AN INCREASED INCIDENCE OF RARE OPPORTUNISTIC FUNGAL PATHOGENS IN THE IMMUNOCOMPROMISED VERY-LOW-BIRTH-WEIGHT (VLBW) INFANT, Pediatric research, 37(4), 1995, pp. 300-300
Authors:
BALCERKUBICZEK EK
HARRISON GH
TORRES BA
MCCREADY WA
Citation: Ek. Balcerkubiczek et al., APPLICATION OF THE CONSTANT EXPOSURE TIME TECHNIQUE TO TRANSFORMATIONEXPERIMENTS WITH FISSION NEUTRONS - FAILURE TO DEMONSTRATE DOSE-RATE DEPENDENCE, International journal of radiation biology, 65(5), 1994, pp. 559-569
Authors:
JOHNSON CM
TORRES BA
KOYAMA H
YAMAMOTO JK
Citation: Cm. Johnson et al., 10TH ANNIVERSARY PERSPECTIVES ON AIDS - FIV AS A MODEL FOR AIDS VACCINATION, AIDS research and human retroviruses, 10(3), 1994, pp. 225-228
Citation: Ba. Torres et al., PRENATAL ADMINISTRATION OF THYROTROPIN-RELEASING-HORMONE AND POSTNATAL THYROXINE VALUES, Lancet, 343(8899), 1994, pp. 730-730